Pharma News, 2020

By integrating its virtual R&D work with real-world laboratory testing data, XtalPi aims to develop a new digital-twin simulation system for modeling the activity of potential new drugs, making it...

Since taking over at Sanofi a year ago, CEO Paul Hudson has made immunology blockbuster Dupixent one of his top priorities—and set some lofty sales goals, too.

A test that can diagnose Covid-19 in minutes will dramatically expand the capacity to detect cases in low- and middle-income countries, the World Health Organization (WHO) has said.

GlaxoSmithKline’s Nucala has been approved by the US Food and Drug Administration (FDA) for the treatment of hypereosinophilic syndrome (HES), making it the first biologic approved i...

Shares of Inovio Pharmaceuticals plunged more than 34% in premarket trading this morning after the company reported the U.

Gilead Science’s Galapagos-partnered oral JAK inhibitor filgotinib has been approved by the European Commission under the brand name Jyseleca for the treatment of moderate-to-severe active rheumatoi...

Days after Johnson & Johnson moved its vaccine candidate into Phase III, the company posted an interim analysis of its Phase I/IIa trial that showed a single dose of JNJ-78436735 induced a strong ...

SYDNEY (Reuters) - Australian biotech company Ena Respiratory said on Monday that a nasal spray it is developing to improve the human immune system to fight common cold and flu significantly r...

BRASILIA (Reuters) - Brazil, which has the world’s second-highest coronavirus death toll, has decided to join the global COVID-19 vaccine partnership known as COVAX and will earmark 2.

Madrid (Spain), September 24, 2020.

SYDNEY, Sept.

ZURICH (Reuters) - An experimental Alzheimer's drug from Roche ROG.